NASDAQ:ASND
Ascendis Pharma (ASND)
Financials 
Technical Analysis 
Jul 24, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Ascendis Pharma (ASND-Q) is showing promising signs of growth, having reached profitability in the last quarter, which has positively influenced investor sentiment. The stock has seen a remarkable rise of 50% this year, reflecting increasing confidence in its technology and market potential. This company's innovative approach to extending the half-life of drugs positions it strongly in the healthcare sector, making it an attractive investment for those looking to capitalize on advancements in biopharmaceuticals. One prominent expert has recently bought shares and expressed an overweight position in healthcare, indicating a bullish outlook towards the sector and Ascendis Pharma in particular.
- «
- ‹
- 1
- ›
- »
Popular Articles
Ascendis Pharma (ASND) Frequently Asked Questions
What is Ascendis Pharma stock symbol?
Ascendis Pharma is a American stock, trading under the symbol ASND (previously ASND-Q on Stockchase) on the NASDAQ (ASND). It is usually referred to as NASDAQ:ASND or ASND
Is Ascendis Pharma a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ASND (previously ASND-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Ascendis Pharma .
Is Ascendis Pharma a good investment or a top pick?
Ascendis Pharma was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Ascendis Pharma .
Why is Ascendis Pharma stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ascendis Pharma .
Is Ascendis Pharma worth watching?
Ascendis Pharma is covered by Stockchase experts and is worth watching.
What is Ascendis Pharma stock price?
On 2026-07-23, Ascendis Pharma (ASND) stock closed at a price of $252.66.
It reached profitability last quarter and is up 50% this year. Their technology extends the half life of drugs. She just bought it. She's overweight healthcare.